Home - Products - Others - Other Targets - 5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone

5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone

CAS No. 141846-47-1

5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone( —— )

Catalog No. M31798 CAS No. 141846-47-1

3'-Dimethylallylkievitone is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 810 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5,7,2,4-Tetrahydroxy-8,3-di(gamma,gamma-dimethylallyl)-isoflavanone
  • Note
    Research use only, not for human use.
  • Brief Description
    3'-Dimethylallylkievitone is a natural product for research related to life sciences.
  • Description
    3'-Dimethylallylkievitone is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    141846-47-1
  • Formula Weight
    424.5
  • Molecular Formula
    C25H28O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Isoferulic acid

    3-Hydroxy-4-methoxycinnamic Acid exhibits hypoglycemic properties.

  • Dehydrocurdione

    Dehydrocurdione, a zedoary-derived sesquiterpene, induces heme oxygenase (HO)-1, an antioxidative enzyme, in RAW 264.7 macrophages. Dehydrocurdione interacts with Keap1, resulting in Nrf2 translocation followed by activation of the HO-1 E2 enhancer. Dehydrocurdione suppresses lipopolysaccharide-induced NO release, a marker of inflammation. Anti-inflammatory activity.

  • LY-3475070

    LY-3475070 is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer.